A detailed history of Sol Capital Management CO transactions in Becton Dickinson & CO stock. As of the latest transaction made, Sol Capital Management CO holds 3,093 shares of BDX stock, worth $724,318. This represents 0.09% of its overall portfolio holdings.

Number of Shares
3,093
Previous 2,693 14.85%
Holding current value
$724,318
Previous $666,000 8.56%
% of portfolio
0.09%
Previous 0.08%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 23, 2024

BUY
$225.07 - $246.17 $90,028 - $98,468
400 Added 14.85%
3,093 $723,000
Q3 2022

Oct 12, 2022

SELL
$51.03 - $264.23 $1,020 - $5,284
-20 Reduced 0.74%
2,693 $600,000
Q1 2022

Apr 18, 2022

SELL
$243.64 - $270.48 $130,347 - $144,706
-535 Reduced 16.47%
2,713 $722,000
Q4 2021

Jan 19, 2022

SELL
$230.08 - $250.94 $13,804 - $15,056
-60 Reduced 1.81%
3,248 $817,000
Q2 2021

Jul 20, 2021

SELL
$232.65 - $254.58 $14,424 - $15,783
-62 Reduced 1.84%
3,308 $804,000
Q2 2020

Jul 31, 2020

SELL
$219.9 - $263.41 $8,796 - $10,536
-40 Reduced 1.17%
3,370 $806,000
Q2 2019

Jul 17, 2019

SELL
$217.4 - $246.08 $7,609 - $8,612
-35 Reduced 1.02%
3,410 $859,000
Q4 2018

Jan 25, 2019

SELL
$204.73 - $257.93 $6,141 - $7,737
-30 Reduced 0.86%
3,445 $776,000
Q3 2018

Oct 29, 2018

SELL
$233.07 - $256.0 $15,149 - $16,640
-65 Reduced 1.84%
3,475 $907,000
Q2 2018

Jul 11, 2018

SELL
$208.1 - $233.85 $15,607 - $17,538
-75 Reduced 2.07%
3,540 $848,000
Q1 2018

Apr 25, 2018

SELL
$205.46 - $240.27 $25,682 - $30,033
-125 Reduced 3.34%
3,615 $783,000
Q4 2017

Jan 31, 2018

SELL
$189.0 - $222.64 $4,725 - $5,566
-25 Reduced 0.66%
3,740 $801,000
Q3 2017

Oct 27, 2017

BUY
$186.89 - $198.9 $703,640 - $748,858
3,765
3,765 $738,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $66.8B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Sol Capital Management CO Portfolio

Follow Sol Capital Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sol Capital Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Sol Capital Management CO with notifications on news.